Roma Vora
Obstetrics & Gynecology · Omaha, NENPI 1093166027
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations.
Across 125 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$475
- Sumitomo Pharma America, Inc.$274
- Astellas Pharma US Inc$190
- Organon$136
- Myovant Sciences Inc.$131
- Bayer$100
- plus $851 from 24 others
What the payments were for
- Food & beverage$2,156100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $475 |
| Sumitomo Pharma America, Inc. | 13 | $274 |
| Astellas Pharma US Inc | 9 | $190 |
| Organon | 8 | $136 |
| Myovant Sciences Inc. | 8 | $131 |
| Bayer | 6 | $100 |
| Daiichi Sankyo Inc. | 6 | $94 |
| Coopersurgical, Inc. | 5 | $91 |
| Novo Nordisk | 6 | $90 |
| Biogen | 5 | $82 |
| Pfizer | 5 | $65 |
| Exeltis, USA Inc. | 3 | $43 |
| Mayne Pharma Commercial LLC | 2 | $39 |
| Seqirus USA Inc | 1 | $30 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Lilly USA, LLC | 2 | $28 |
| Medtronic | 2 | $26 |
| Therapeuticsmd, Inc. | 2 | $25 |
| Boston Scientific | 1 | $24 |
| Smith+Nephew | 1 | $22 |
| Sanara Medtech Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Abbott | 1 | $16 |
| Gynesonics, Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Merck | 1 | $13 |
How this compares
$2,156 in reported general payments places this provider in the 75th percentile of 242 obstetrics & gynecology providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $1,344 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Omaha
- John CoteOmaha$236K
- Robin ClemmerOmaha$19K
- Susan UlmerOmaha$8K
- Jennifer CeraOmaha$5K
- Trevor WatsonOmaha$5K
- Jamie SeemanOmaha$4K
- Malorie HoweOmaha$4K
- Sonya TranOmaha$3K
- Jessica Prusa FloresOmaha$3K
- Tedette EllisOmaha$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.